News & Impact

You are here

News for Neurodegenerative Diseases

Showing 1 - 6 of 33 total
Person walking and field of tulips
NEWS: 
Article
A diagnosis of Parkinson’s Disease can be quite challenging for patients and their families. Since April is Parkinson’s Disease Awareness Month, it’s a perfect time to highlight the importance of exercise in reducing symptoms and improving quality of life in people living with PD.
David's photo
NEWS: 
Article
We are very pleased to announce that Dr. David Gould will be joining the Burke Neurological Institute (BNI) as Chief Operating Officer starting in early April.
News Highlights of 2020
NEWS: 
Article

As we look back, our news highlights during the pandemic year of 2020 spotlight how we joined together to overcome challenges to carry on with our mission to find cures for chronic neurological disabilities.

Gibson Team in the Lab
NEWS: 
In the Media
Media Outlet: 
CNN Health
Benfotiamine and Cognitive Decline in Alzheimer's Disease, a small exploratory clinical trial, conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute is listed in CNN Health’s article on ”Top 2020 health stories you may have missed because of Covid-19” under Advances in Alzheimer’s.
Photo of Gibson Lab
NEWS: 
Article
A small exploratory clinical trial conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute in collaboration with physicians at the Burke Rehabilitation Hospital, suggests that Benfotiamine is safe and potentially efficacious in improving cognitive outcomes among people living with Mild Cognitive Impairment and mild Alzheimer’s disease (AD).
Zhong Lab returning to lab
NEWS: 
Article
We are proud to be a strong team dedicated to spinal cord injury research, and proud to embark on our first phase I clinical trial soon.